It’s fall 2020 and the world’s waiting for the first results from the vaccine trials. But as the moment of truth nears, the pressure on the vaccine makers intensifies. And while AstraZeneca and Johnson & Johnson get hit with curveballs, Pfizer finds itself caught in the crossfire of the U.S. Presidential election. Listen to new episodes 1 week early and to all episodes ad free with Wondery+. Join Wondery+ for exclusives, binges, early access, and ad free listening. Available in the Wondery App https://wondery.app.link/businesswars. Support us by supporting our sponsors! See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

BioNTech, Moderna, Johnson & Johnson, AstraZeneca. These companies are now household names thanks to their COVID-19 vaccines. The gambles these businesses took are paying off.  The pharmaceutical giants are in line to profit heavily from their life-saving work, but the system of distributing the vaccines has seen its fair share of hiccups and controversy. We spoke to Annalisa Merelli, a healthcare reporter for Quartz about the pandemic, the economic effects of the vaccine rollout and the current surge in COVID cases in India. Listen to new episodes 1 week early and to all episodes ad free with Wondery+. Join Wondery+ for exclusives, binges, early access, and ad free listening. Available in the Wondery App https://wondery.app.link/businesswars. Support us by supporting our sponsors! See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.